NCT05254899 2022-02-24
Anti-PD-1 Antibody and P-GEMOX Chemotherapy Combined With Radiotherapy in High-risk Early-Stage ENKTL
ChineseAMS
Phase 2 Unknown
Clinical Trials
10 trialsNCT05149170 2021-12-08
Radiotherapy and Anti-PD-1 in Low-risk ES-ENKTCL
ChineseAMS
Phase 2 Unknown
NCT04994626 2021-08-06
Ibrutinib Combined With Rituximab for Treatment of Relapsed Refractory MYD88 and CD79A/B (or CD79B Alone) DLBCL Who Have Received at Least Two Prior Therapies
ChineseAMS
Phase 2 Unknown
NCT04511351 2020-08-13
Radiotherapy Combined With GDP With or Without Chidamide in Stage I/II Extranodal Nasal NK/T-cell Lymphoma
ChineseAMS
Phase NA Unknown
NCT04425824 2020-06-16
Toripalimab Combine With Rituximab for Treatment of Relapsed Refractory CD20 Positive Diffuse Large B-cell Lymphoma
ChineseAMS
Phase 2 Unknown
NCT03731390 2018-11-06
GR1405 Injection in Patients With Advanced Solid Tumor or Lymphoma
ChineseAMS
Phase 1 Unknown
NCT02560441 2018-01-03
Trial of IPGDP Regimen Chemotherapy in Patients With Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
ChineseAMS
Phase 2 Unknown
NCT02404571 2016-07-26
GDP in Frontline Chemotherapy for Patients With PTCL-NOS
ChineseAMS
Phase 2 Unknown
NCT01412307 2015-08-11
LEBEN
GiovanniPascale
Phase 1/2 Unknown
NCT01156259 2010-07-02
30Gy Versus 40Gy Involved-field Radiotherapy for Localized Diffuse Large B Cell Lymphoma Achieving CR After Chemotherapy
ChineseAMS
Phase 3 Unknown